Picture Campus Berlin-Buch GmbH CBB Location of Future Innovation 650x100px
Person › Details

Stéphane Boissel (SparingVision S.A.S.)

Boissel, Stéphane (SparingVision 202010– CEO before Sangamo + TxCell + Genclis + Transgene + Innate Pharma + Lazard)


Organisations Organisation SparingVision S.A.S.
  Former/major organisation TxCell S.A. (Euronext Paris: TXCL)
Products Product SPVN06 mutation-agnostic AAV gene therapy for ofretinitis pigmentosa (SparingVision)
  Product 2 gene therapy


Picture Wirtschaftsförderung Sachsen Life Sciences in Saxony 650x200px

More documents for Stéphane Boissel

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Campus Berlin-Buch GmbH BBC BerlinBioCube Start-up Center 650x300px

» top